EIDOS THERAPEUTICS, INC. Proceeds from Stock Options Exercised
EIDOS THERAPEUTICS, INC. reported Proceeds from Stock Options Exercised of $643.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2020-10-29
- EIDOS THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2020-09-30 was $247.00K, a 4.66% increase year-over-year.
- EIDOS THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2020-06-30 was $204.00K, a 134.48% increase year-over-year.
- EIDOS THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2020-03-31 was $192.00K, a 668.00% increase year-over-year.
- EIDOS THERAPEUTICS, INC. proceeds from stock options exercised for the quarter ending 2019-12-31 was $662.00K, a 3052.38% increase year-over-year.
- EIDOS THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2019 was $1.01M, a 952.08% increase from fiscal 2018.
- EIDOS THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2018 was $96.00K, a 69.81% decline from fiscal 2017.
- EIDOS THERAPEUTICS, INC. proceeds from stock options exercised for fiscal 2017 was $318.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2020-09-30 | $247.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $451.00K derived: sum of 2 quarters · filed 2020-10-29 | $643.00K 10-Q · filed 2020-10-29 | $1.30M derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-06-30 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $396.00K 10-Q · filed 2020-08-06 | $1.06M derived: sum of 3 quarters · filed 2020-08-06 | $1.29M derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-03-31 | $192.00K 10-Q · filed 2020-05-08 | $854.00K derived: sum of 2 quarters · filed 2020-05-08 | $1.09M derived: sum of 3 quarters · filed 2020-10-29 | $1.18M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-12-31 | $662.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $898.00K derived: sum of 2 quarters · filed 2020-10-29 | $985.00K derived: sum of 3 quarters · filed 2020-10-29 | $1.01M 10-K · filed 2020-02-26 |
| 2019-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $323.00K derived: sum of 2 quarters · filed 2020-10-29 | $348.00K 10-Q · filed 2020-10-29 | $369.00K derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $112.00K 10-Q · filed 2020-08-06 | $133.00K derived: sum of 3 quarters · filed 2020-08-06 | |
| 2019-03-31 | $25.00K 10-Q · filed 2020-05-08 | $46.00K derived: sum of 2 quarters · filed 2020-05-08 | ||
| 2018-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $96.00K 10-K · filed 2020-02-26 | ||
| 2018-09-30 | $75.00K 10-Q · filed 2019-10-31 | |||
| 2017-12-31 | $318.00K 10-K · filed 2020-02-26 |